Practical Insights of RBM Application
Join the Cyntegrity’s CEO, Dr. Artem Andrianov, who will be speaking about the practical aspects of the RBM application covering the following sub-topics:
- Review the definition of Risk-based Monitoring (RBM) in clinical research and statistical surveillance. Difference of views between FDA and EMA
- Answer “What it’s in it for me?” question.
- Share real-life examples of the RBM application and its pitfalls
- Identify the difficulties & potential pitfalls of RBM application